The histology of kidney transplant failure: A long-term follow-up study

Transplantation

Volumn 98, Issue 4, 2014, Pages 427-435

  Naesens, Maarten ^a,b   Kuypers, Dirk R J ^a,b   De Vusser, Katrien ^a,b   Evenepoel, Pieter ^a,b   Claes, Kathleen ^a,b   Bammens, Bert ^a,b   Meijers, Björn ^a,b   Sprangers, Ben ^a,b   Pirenne, Jacques ^a,b   Monbaliu, Diethard ^a,b   Jochmans, Ina ^a,b   Lerut, Evelyne ^a,c  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c DEPARTMENT OF IMAGING AND PATHOLOGY   (Belgium)

Author keywords

Graft outcome; Histology; Kidney transplantation; Survival analysis

Indexed keywords

ANTIBODY MEDIATED REJECTION; ARTICLE; FOLLOW UP; GLOMERULOPATHY; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOLOGY; HUMAN; HUMAN TISSUE; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY TRANSPLANTATION; KIDNEY TUBULE DISORDER; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; POLYOMAVIRUS NEPHROPATHY; PRIORITY JOURNAL; T CELL MEDIATED REJECTION; TUBULAR ATROPHY; ALLOTRANSPLANTATION; BIOPSY; KIDNEY; PATHOLOGY; RISK FACTOR;

BIOPSY; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; RISK FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84908006802     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000183     Document Type: Article

References (26)

1. Lamb KE, Lodhi S, Meier-Kriesche HU. Long-term renal allograft survival in the United States: a critical reappraisal. Am J Transplant 2011; 11: 450.
2. El-Zoghby ZM, Stegall MD, Lager DJ, et al. Identifying specific causes of kidney allograft loss. Am J Transplant 2009; 9: 527.
3. Sellares J, De Freitas DG, Mengel M, et al. Inflammation lesions in kidney transplant biopsies: association with survival is due to the underlying diseases. Am J Transplant 2011; 11: 489.
4. Sis B, Einecke G, Chang J, et al. Cluster analysis of lesions in non-selected kidney transplant biopsies: microcirculation changes, tubulo-interstitial inflammation and scarring. Am J Transplant 2010; 10: 421.
5. Naesens M, Kuypers DR, De Vusser K, et al. Chronic histological damage in early indication biopsies is an independent risk factor for late renal allograft failure. Am J Transplant 2013; 13: 86.
6. Mannon RB. Immune monitoring and biomarkers to predict chronic allograft dysfunction. Kidney Int Suppl 2010; 119: S59.
7. Naesens M, Kuypers DR, Sarwal M. Calcineurin inhibitor nephro-toxicity. Clin J Am Soc Nephrol 2009; 4: 481.
8. El Ters M, Grande JP, Keddis MT, et al. Kidney allograft survival after acute rejection, the value of follow-up biopsies. Am J Transplant 2013; 13: 2334.
9. Bohle A, Wehrmann M, Bogenschutz O, et al. The pathogenesis of chronic renal failure in diabetic nephropathy. Investigation of 488 cases of diabetic glomerulosclerosis. Pathol Res Pract 1991; 187: 251.
10. Wehrmann M, Bohle A, Held H, et al. Long-term prognosis of focal sclerosing glomerulonephritis. An analysis of 250 cases with particular regard to tubulointerstitial changes. Clin Nephrol 1990; 33: 115.
11. Schmitt H, Bohle A, Reineke T, et al. Long-term prognosis of membranoproliferative glomerulonephritis type I. Significance of clinical and morphological parameters: an investigation of 220 cases. Nephron 1990; 55: 242.
12. Bogenschutz O, Bohle A, Batz C, et al. IgA nephritis: on the importance of morphological and clinical parameters in the long-term prognosis of 239 patients. Am J Nephrol 1990; 10: 137.
13. AWorking Group of the International IgA Nephropathy Network and the Renal Pathology Society. The Oxford classification of IgA ne-phropathy: rationale, clinicopathological correlations, and classification. Kidney Int 2009; 76: 534.
14. Berden AE, Ferrario F, Hagen EC, et al. Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol 2010; 21: 1628.
15. Pascual M, Theruvath T, Kawai T, et al. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002; 346: 580.
16. Halloran PF, Melk A, Barth C. Rethinking chronic allograft ne-phropathy: the concept of accelerated senescence. J Am Soc Nephrol 1999; 10: 167.
17. Park WD, Griffin MD, Cornell LD, et al. Fibrosis with inflammation at one year predicts transplant functional decline. J Am Soc Nephrol 2010; 21: 1987.
18. Naesens M, Khatri P, Li L, et al. Progressive histological damage in renal allografts is associated with expression of innate and adaptive immunity genes. Kidney Int 2011; 80: 1364.
19. Gaston RS, Cecka JM, Kasiske BL, et al. Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure. Transplantation 2010; 90: 68.
20. Nankivell BJ, Richard J, Borrows RJ, et al. The natural history of chronic allograft nephropathy. N Engl J Med 2003; 349: 2326.
21. Sis B, Jhangri GS, Bunnag S, et al. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 2009; 9: 2312.
22. Loupy A, Hill GS, Suberbielle C, et al. Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA). Am J Transplant 2011; 11: 56.
23. Haas M. C4d-negative antibody-mediated rejection in renal allografts: evidence for its existence and effect on graft survival. Clin Nephrol 2011; 75: 271.
24. Mengel M, Sis B, Haas M, et al. Banff 2011 meeting report: new concepts in antibody-mediated rejection. Am J Transplant 2012; 12: 563.
25. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008; 8: 753.
26. Sis B, Mengel M, Haas M, et al. Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 2010; 10: 464.